Urine-based methylation assay for urothelial carcinoma

· Shanghai Epiprobe Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Urine-based methylation assay for urothelial carcinoma, covering 2025-04-08 to 2025-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Performance Evaluation of a Urine-based Methylation Assay for Urothelial Carcinoma

See pricing